newsfilter
← Latest News
GlobeNewswire·

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne muscular dystrophyBLA supported by positive pivotal HOPE-3 Phase 3 results, including achievement